Bafetinib (INNO-406)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Bafetinib (INNO-406), covering 2011-12-15 to 2013-05-15. Get the full timeline:
Most recent: Clinical Trial Update: Study of Bafetinib as Treatment for Relapsed or Refractory B-Cell Chronic Lymphocytic Leukemia (B-CLL) [Phase 2]